Bundles or Enzyme Finance: Which Fits Your Needs in 2026?

Bundles is the more direct choice if you want a token representing a selected group of crypto assets on Ethereum. You choose a bundle such as CORE, BLUE or GFO, then acquire its ERC-20 token. Bundles says the portfolios rebalance automatically, but each bundle has its own holdings and risks; check the assets and allocations rather than treating the token as broad-market exposure. Every bundle must also include at least 5% BUN.

Enzyme Finance is aimed more at organizations and finance professionals than at someone seeking a straightforward buy-and-hold app. Onyx supports tokenized fund issuance and administration, Blue is for decentralized strategies, and Myso supports covered calls and cash-secured puts. Its APIs, SDKs and white-label options may matter to businesses building financial products, but mean you need to assess the specific Enzyme product and deployment. Pick based on whether you want a basket token or infrastructure for managing or issuing financial products.

Neither gives you a complete published fee schedule in the information described here, so you cannot make a reliable cost comparison from headline pricing alone. Bundles says swap and rebalancing fees apply and that BUN is used to pay them, but the rates are not published. Ask when each charge is applied and check the transaction preview before approving a trade.

You should also account for Ethereum gas when using Bundles; the amount varies with network conditions. Swapping into or out of a bundle may add costs beyond gas and the stated platform fees. Enzyme’s pricing needs confirmation by product: do not assume Onyx, Blue and Myso share one price. Ask for a written breakdown covering setup, ongoing administration, integrations, trading or settlement, and usage-based charges. On-chain transaction costs may be separate from Enzyme’s platform pricing. If predictable costs are essential, neither is an easy choice until you have confirmed the full schedule for your intended use.

Neither platform should be treated as risk-free. Bundles has no audit listed, and its published details do not establish who can upgrade or pause contracts, how custody works, or how redemption works. The project describes bundle tokens as on-chain ERC-20 assets, but that alone does not explain who controls the contracts or what happens if something goes wrong. Check contract addresses, permissions, holdings and exit mechanics before putting funds in.

Enzyme has two audits listed and describes security controls and Vault infrastructure as independently audited. The scope, dates and coverage of current products are not established, so ask for the reports and confirm which deployed contracts they cover. Enzyme’s references to compliance frameworks do not establish that it holds a licence or that a particular product is compliant where you operate. Confirm custody, permissions and legal terms for the exact deployment. An audit is useful evidence to examine, not a guarantee against loss.

Bundles has the more understandable starting concept: choose a portfolio and acquire its Ethereum ERC-20 token. You will need a compatible wallet and ETH for gas. The specific supported wallets, mobile availability and sign-up requirements are not published in the information described here, so confirm them before connecting. Review the token, contract address, transaction amount and permissions in your wallet before you approve anything.

Enzyme is less straightforward for a retail user because it serves several different use cases and offers product-specific access points. It lists Ethereum, Polygon and Arbitrum for the protocol, while Onyx deployments may use other networks; do not assume every product or asset is available on every chain. Builders may find documentation, APIs and SDKs relevant, but businesses should establish which product, network and contracts match their plans. Neither provides a confirmed standard retail onboarding flow, so Bundles is the simpler concept, not a guarantee of easier or safer execution.

Bundles’ main advantage is focus: it packages selected assets into a single Ethereum token and says it rebalances automatically. That can be more convenient than managing several holdings separately, but it does not remove the need to inspect the portfolio. The required BUN allocation, unknown fee rates and unclear redemption details are material trade-offs. Consider whether you want BUN exposure and can verify the bundle’s holdings and exit route.

Enzyme’s advantage is breadth for professional or business use. Onyx, Blue and Myso address different activities, while APIs, SDKs and white-label options may help teams integrate on-chain financial products. That range is not the same as a simple retail investing experience. Pricing, custody and licensing need direct confirmation, and the audits need to be checked against the relevant deployment. If your goal is a basket token, Enzyme may be more platform than you need; if you are issuing or managing a financial product, Bundles does not serve the same purpose.